Legato Capital Management LLC Has $561,000 Stake in LeMaitre Vascular, Inc. $LMAT

Legato Capital Management LLC decreased its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 48.8% in the 4th quarter, Holdings Channel.com reports. The firm owned 6,922 shares of the medical instruments supplier’s stock after selling 6,597 shares during the period. Legato Capital Management LLC’s holdings in LeMaitre Vascular were worth $561,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. State of Alaska Department of Revenue grew its holdings in LeMaitre Vascular by 1.2% during the 4th quarter. State of Alaska Department of Revenue now owns 11,986 shares of the medical instruments supplier’s stock worth $971,000 after acquiring an additional 147 shares during the last quarter. Johnson Investment Counsel Inc. grew its holdings in LeMaitre Vascular by 0.5% during the 3rd quarter. Johnson Investment Counsel Inc. now owns 29,792 shares of the medical instruments supplier’s stock worth $2,607,000 after acquiring an additional 153 shares during the last quarter. Federated Hermes Inc. grew its holdings in LeMaitre Vascular by 0.4% during the 2nd quarter. Federated Hermes Inc. now owns 39,659 shares of the medical instruments supplier’s stock worth $3,294,000 after acquiring an additional 155 shares during the last quarter. Jones Financial Companies Lllp grew its holdings in LeMaitre Vascular by 2.2% during the 3rd quarter. Jones Financial Companies Lllp now owns 7,486 shares of the medical instruments supplier’s stock worth $630,000 after acquiring an additional 158 shares during the last quarter. Finally, Illinois Municipal Retirement Fund grew its holdings in LeMaitre Vascular by 1.6% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 11,048 shares of the medical instruments supplier’s stock worth $967,000 after acquiring an additional 171 shares during the last quarter. Institutional investors and hedge funds own 84.64% of the company’s stock.

LeMaitre Vascular Stock Up 1.0%

Shares of NASDAQ LMAT opened at $98.71 on Wednesday. The company has a market capitalization of $2.26 billion, a P/E ratio of 36.42, a price-to-earnings-growth ratio of 2.72 and a beta of 0.60. LeMaitre Vascular, Inc. has a 52-week low of $79.00 and a 52-week high of $118.01. The company has a debt-to-equity ratio of 0.42, a quick ratio of 12.20 and a current ratio of 14.32. The company’s 50 day moving average price is $108.17 and its 200-day moving average price is $95.53.

LeMaitre Vascular (NASDAQ:LMAT) last issued its quarterly earnings results on Tuesday, May 5th. The medical instruments supplier reported $0.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.66 by $0.02. The firm had revenue of $66.55 million for the quarter, compared to the consensus estimate of $66.67 million. LeMaitre Vascular had a net margin of 24.35% and a return on equity of 15.36%. The company’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.48 EPS. LeMaitre Vascular has set its FY 2026 guidance at 2.930-3.080 EPS and its Q2 2026 guidance at 0.790-0.840 EPS. Equities analysts forecast that LeMaitre Vascular, Inc. will post 3 earnings per share for the current year.

LeMaitre Vascular Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 4th. Stockholders of record on Thursday, May 21st will be given a $0.25 dividend. The ex-dividend date is Thursday, May 21st. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.0%. LeMaitre Vascular’s payout ratio is 36.90%.

Insider Activity

In other news, CEO George W. Lemaitre sold 150,000 shares of the business’s stock in a transaction that occurred on Thursday, February 26th. The shares were sold at an average price of $106.76, for a total value of $16,014,000.00. Following the transaction, the chief executive officer owned 1,532,304 shares in the company, valued at approximately $163,588,775.04. The trade was a 8.92% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Trent G. Kamke sold 2,928 shares of the business’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $107.00, for a total transaction of $313,296.00. Following the transaction, the insider owned 3,749 shares in the company, valued at $401,143. The trade was a 43.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 269,891 shares of company stock worth $28,969,086 over the last quarter. Company insiders own 7.40% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on LMAT shares. Citizens Jmp boosted their target price on shares of LeMaitre Vascular from $118.00 to $127.00 and gave the stock a “market outperform” rating in a report on Wednesday, May 6th. Weiss Ratings raised shares of LeMaitre Vascular from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, May 20th. Freedom Capital raised shares of LeMaitre Vascular to a “hold” rating in a report on Tuesday, March 31st. Wells Fargo & Company boosted their target price on shares of LeMaitre Vascular from $94.00 to $104.00 and gave the stock an “equal weight” rating in a report on Wednesday, May 6th. Finally, Roth Mkm reissued a “buy” rating and set a $117.00 target price (up from $108.00) on shares of LeMaitre Vascular in a report on Thursday, February 26th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, LeMaitre Vascular currently has an average rating of “Moderate Buy” and a consensus price target of $112.60.

About LeMaitre Vascular

LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company’s offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre’s product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.

Founded in 1983 by George D.